![Second Generation Antidepressants for Pediatric Patients with Major Depressive Disorder and Anxiety Disorder: A Review of the Clinical Effectiveness and Safety - NCBI Bookshelf Second Generation Antidepressants for Pediatric Patients with Major Depressive Disorder and Anxiety Disorder: A Review of the Clinical Effectiveness and Safety - NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-rc0667-lrg.png)
Second Generation Antidepressants for Pediatric Patients with Major Depressive Disorder and Anxiety Disorder: A Review of the Clinical Effectiveness and Safety - NCBI Bookshelf
![Second-Generation Antidepressants in the Pharmacologic Treatment of Adult Depression: An Update of the 2007 Comparative Effectiveness Review First Last, - ppt download Second-Generation Antidepressants in the Pharmacologic Treatment of Adult Depression: An Update of the 2007 Comparative Effectiveness Review First Last, - ppt download](https://images.slideplayer.com/19/5727022/slides/slide_15.jpg)
Second-Generation Antidepressants in the Pharmacologic Treatment of Adult Depression: An Update of the 2007 Comparative Effectiveness Review First Last, - ppt download
![PDF] Using second-generation antidepressants to treat depressive disorders: a clinical practice guideline from the American College of Physicians. | Semantic Scholar PDF] Using second-generation antidepressants to treat depressive disorders: a clinical practice guideline from the American College of Physicians. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/2f2819fd92c368af9329abe73a950eff20f75caa/2-Table1-1.png)
PDF] Using second-generation antidepressants to treat depressive disorders: a clinical practice guideline from the American College of Physicians. | Semantic Scholar
![Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis - The Lancet Psychiatry Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis - The Lancet Psychiatry](https://www.thelancet.com/cms/attachment/f605d7cd-a328-4cda-8e75-4fd65f5651a2/gr1.gif)
Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis - The Lancet Psychiatry
![Frontiers | Antidepressants in Children and Adolescents: Meta-Review of Efficacy, Tolerability and Suicidality in Acute Treatment Frontiers | Antidepressants in Children and Adolescents: Meta-Review of Efficacy, Tolerability and Suicidality in Acute Treatment](https://www.frontiersin.org/files/Articles/527732/fpsyt-11-00717-HTML/image_m/fpsyt-11-00717-g001.jpg)
Frontiers | Antidepressants in Children and Adolescents: Meta-Review of Efficacy, Tolerability and Suicidality in Acute Treatment
![Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis - The Lancet Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis - The Lancet](https://www.thelancet.com/cms/attachment/2000996554/2003695250/gr1.gif)
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis - The Lancet
![Second-Generation Antipsychotics for Treatment-Resistant Major Depressive Disorder in Primary Care | Consultant360 Second-Generation Antipsychotics for Treatment-Resistant Major Depressive Disorder in Primary Care | Consultant360](https://s3.amazonaws.com/HMP/c360/imported/transfer/Screen_Shot_2016-03-10_at_1.38.27_PM.png)
Second-Generation Antipsychotics for Treatment-Resistant Major Depressive Disorder in Primary Care | Consultant360
![priSMa diagram for second generation antidepressants versus cognitive... | Download Scientific Diagram priSMa diagram for second generation antidepressants versus cognitive... | Download Scientific Diagram](https://www.researchgate.net/publication/286409762/figure/fig1/AS:614010546315277@1523402930618/priSMa-diagram-for-second-generation-antidepressants-versus-cognitive-behavioral.png)